Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-01-23

Clinical Trial Update: Combined Oral Contraceptives and Fluoxetine Versus Combined Oral Contraceptives in Severe Premenstrual Syndrome [Phase 3]

View source ↗

Summary

Phase 3 trial update comparing combined oral contraceptives with fluoxetine versus combined oral contraceptives alone for severe premenstrual syndrome; sponsor …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Combined oral contraceptives
  • Fluoxetine (Fluoxetine)

Snippet

Sponsor: Cairo University | Conditions: Premenstrual Syndrome | Phase 3 | Status: UNKNOWN